Belgian molecular diagnostics company Biocartis Group said on Thursday it had entered into an agreement with British drugmaker AstraZeneca to obtain faster lung cancer molecular diagnostic biomarker results in Europe.
from Latest News https://ift.tt/2E5DSRx
No comments:
Post a Comment